Drug Repurposing Market - Global Outlook and Forecast 2022-2028

March 2022 | 62 pages | ID: D778BCDD25D4EN
Market Monitor Global

Abstracts

Drug repurposing or re-profiling has been the hallmark to bring strong business growth and the trend is being followed by majority of the pharmaceutical and biopharmaceutical companies. Among all biologics approved in the U.S. during 2007-2009, 30-40% of them were the drugs repurposed or repositioned. National Institute of Health (NIH), U.S. Department of Health defines drug repurposing as discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside. Drug repurposing opens up various opportunities to answer current unmet medical needs to come up with cost-effective solutions to expensive drug development process. Repurposing or re-profiling of drugs which are suspended due to lack of efficacy or specificity can be a good start over for further development for new indication. Finding new indications for already studied drugs can benefit patients by getting quick access to new treatment choices and also to developer by saving time and money while maintaining its original IP protection. For many expensive indications such as cancer, scrutinizing for anti-cancer activity among dozens of off-patent drugs that have already established their safety is a powerful method opted by majority of the big pharma companies. However, repurposing is not a new strategy and there are bunch of drugs which are repositioned or repurposed, some of them are Raloxifene (approved for treatment of osteoporosis in 2007, originally indicated for breast cancer treatment), Thalidomide (repositioned for use in treatment of leprosy and multiple myeloma in 2006), Rapamycin (repurposed in 1999 for prevention of organ transplant rejection), Sildenafil (originally approved for erectile dysfunction and recently got approved for treatment of angina) and many others.

This report contains market size and forecasts of Drug Repurposing in Global, including the following market information:

Global Drug Repurposing Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Drug Repurposing market was valued at 25280 million in 2021 and is projected to reach US$ 30620 million by 2028, at a CAGR of 2.8% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oncology Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Drug Repurposing include Astellas Pharma, Biovista, Novartis, AbbVie, Pfizer, Allergan and NuMedii, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drug Repurposing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Drug Repurposing Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Drug Repurposing Market Segment Percentages, by Type, 2021 (%)

• Oncology
• CNS Diseases
• Neurodegenerative Diseases
• Others

Global Drug Repurposing Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Drug Repurposing Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Ambulatory Surgical Centers
• Others

Global Drug Repurposing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Drug Repurposing Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Drug Repurposing revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Drug Repurposing revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Astellas Pharma
• Biovista
• Novartis
• AbbVie
• Pfizer
• Allergan
• NuMedii

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Drug Repurposing Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Drug Repurposing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DRUG REPURPOSING OVERALL MARKET SIZE

2.1 Global Drug Repurposing Market Size: 2021 VS 2028
2.2 Global Drug Repurposing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Drug Repurposing Players in Global Market
3.2 Top Global Drug Repurposing Companies Ranked by Revenue
3.3 Global Drug Repurposing Revenue by Companies
3.4 Top 3 and Top 5 Drug Repurposing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Drug Repurposing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drug Repurposing Players in Global Market
  3.6.1 List of Global Tier 1 Drug Repurposing Companies
  3.6.2 List of Global Tier 2 and Tier 3 Drug Repurposing Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Drug Repurposing Market Size Markets, 2021 & 2028
  4.1.2 Oncology
  4.1.3 CNS Diseases
  4.1.4 Neurodegenerative Diseases
  4.1.5 Others
4.2 By Type - Global Drug Repurposing Revenue & Forecasts
  4.2.1 By Type - Global Drug Repurposing Revenue, 2017-2022
  4.2.2 By Type - Global Drug Repurposing Revenue, 2023-2028
  4.2.3 By Type - Global Drug Repurposing Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Drug Repurposing Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Ambulatory Surgical Centers
  5.1.4 Others
5.2 By Application - Global Drug Repurposing Revenue & Forecasts
  5.2.1 By Application - Global Drug Repurposing Revenue, 2017-2022
  5.2.2 By Application - Global Drug Repurposing Revenue, 2023-2028
  5.2.3 By Application - Global Drug Repurposing Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Drug Repurposing Market Size, 2021 & 2028
6.2 By Region - Global Drug Repurposing Revenue & Forecasts
  6.2.1 By Region - Global Drug Repurposing Revenue, 2017-2022
  6.2.2 By Region - Global Drug Repurposing Revenue, 2023-2028
  6.2.3 By Region - Global Drug Repurposing Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Drug Repurposing Revenue, 2017-2028
  6.3.2 US Drug Repurposing Market Size, 2017-2028
  6.3.3 Canada Drug Repurposing Market Size, 2017-2028
  6.3.4 Mexico Drug Repurposing Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Drug Repurposing Revenue, 2017-2028
  6.4.2 Germany Drug Repurposing Market Size, 2017-2028
  6.4.3 France Drug Repurposing Market Size, 2017-2028
  6.4.4 U.K. Drug Repurposing Market Size, 2017-2028
  6.4.5 Italy Drug Repurposing Market Size, 2017-2028
  6.4.6 Russia Drug Repurposing Market Size, 2017-2028
  6.4.7 Nordic Countries Drug Repurposing Market Size, 2017-2028
  6.4.8 Benelux Drug Repurposing Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Drug Repurposing Revenue, 2017-2028
  6.5.2 China Drug Repurposing Market Size, 2017-2028
  6.5.3 Japan Drug Repurposing Market Size, 2017-2028
  6.5.4 South Korea Drug Repurposing Market Size, 2017-2028
  6.5.5 Southeast Asia Drug Repurposing Market Size, 2017-2028
  6.5.6 India Drug Repurposing Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Drug Repurposing Revenue, 2017-2028
  6.6.2 Brazil Drug Repurposing Market Size, 2017-2028
  6.6.3 Argentina Drug Repurposing Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Drug Repurposing Revenue, 2017-2028
  6.7.2 Turkey Drug Repurposing Market Size, 2017-2028
  6.7.3 Israel Drug Repurposing Market Size, 2017-2028
  6.7.4 Saudi Arabia Drug Repurposing Market Size, 2017-2028
  6.7.5 UAE Drug Repurposing Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Astellas Pharma
  7.1.1 Astellas Pharma Corporate Summary
  7.1.2 Astellas Pharma Business Overview
  7.1.3 Astellas Pharma Drug Repurposing Major Product Offerings
  7.1.4 Astellas Pharma Drug Repurposing Revenue in Global Market (2017-2022)
  7.1.5 Astellas Pharma Key News
7.2 Biovista
  7.2.1 Biovista Corporate Summary
  7.2.2 Biovista Business Overview
  7.2.3 Biovista Drug Repurposing Major Product Offerings
  7.2.4 Biovista Drug Repurposing Revenue in Global Market (2017-2022)
  7.2.5 Biovista Key News
7.3 Novartis
  7.3.1 Novartis Corporate Summary
  7.3.2 Novartis Business Overview
  7.3.3 Novartis Drug Repurposing Major Product Offerings
  7.3.4 Novartis Drug Repurposing Revenue in Global Market (2017-2022)
  7.3.5 Novartis Key News
7.4 AbbVie
  7.4.1 AbbVie Corporate Summary
  7.4.2 AbbVie Business Overview
  7.4.3 AbbVie Drug Repurposing Major Product Offerings
  7.4.4 AbbVie Drug Repurposing Revenue in Global Market (2017-2022)
  7.4.5 AbbVie Key News
7.5 Pfizer
  7.5.1 Pfizer Corporate Summary
  7.5.2 Pfizer Business Overview
  7.5.3 Pfizer Drug Repurposing Major Product Offerings
  7.5.4 Pfizer Drug Repurposing Revenue in Global Market (2017-2022)
  7.5.5 Pfizer Key News
7.6 Allergan
  7.6.1 Allergan Corporate Summary
  7.6.2 Allergan Business Overview
  7.6.3 Allergan Drug Repurposing Major Product Offerings
  7.6.4 Allergan Drug Repurposing Revenue in Global Market (2017-2022)
  7.6.5 Allergan Key News
7.7 NuMedii
  7.7.1 NuMedii Corporate Summary
  7.7.2 NuMedii Business Overview
  7.7.3 NuMedii Drug Repurposing Major Product Offerings
  7.7.4 NuMedii Drug Repurposing Revenue in Global Market (2017-2022)
  7.7.5 NuMedii Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Drug Repurposing Market Opportunities & Trends in Global Market
Table 2. Drug Repurposing Market Drivers in Global Market
Table 3. Drug Repurposing Market Restraints in Global Market
Table 4. Key Players of Drug Repurposing in Global Market
Table 5. Top Drug Repurposing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Drug Repurposing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Drug Repurposing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Drug Repurposing Product Type
Table 9. List of Global Tier 1 Drug Repurposing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drug Repurposing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Drug Repurposing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Drug Repurposing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Drug Repurposing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Drug Repurposing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Drug Repurposing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Drug Repurposing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Drug Repurposing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Drug Repurposing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Drug Repurposing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Drug Repurposing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Drug Repurposing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Drug Repurposing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Drug Repurposing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Drug Repurposing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Drug Repurposing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Drug Repurposing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Drug Repurposing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Drug Repurposing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Drug Repurposing Revenue, (US$, Mn), 2023-2028
Table 30. Astellas Pharma Corporate Summary
Table 31. Astellas Pharma Drug Repurposing Product Offerings
Table 32. Astellas Pharma Drug Repurposing Revenue (US$, Mn), (2017-2022)
Table 33. Biovista Corporate Summary
Table 34. Biovista Drug Repurposing Product Offerings
Table 35. Biovista Drug Repurposing Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Drug Repurposing Product Offerings
Table 38. Novartis Drug Repurposing Revenue (US$, Mn), (2017-2022)
Table 39. AbbVie Corporate Summary
Table 40. AbbVie Drug Repurposing Product Offerings
Table 41. AbbVie Drug Repurposing Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Drug Repurposing Product Offerings
Table 44. Pfizer Drug Repurposing Revenue (US$, Mn), (2017-2022)
Table 45. Allergan Corporate Summary
Table 46. Allergan Drug Repurposing Product Offerings
Table 47. Allergan Drug Repurposing Revenue (US$, Mn), (2017-2022)
Table 48. NuMedii Corporate Summary
Table 49. NuMedii Drug Repurposing Product Offerings
Table 50. NuMedii Drug Repurposing Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Drug Repurposing Segment by Type in 2021
Figure 2. Drug Repurposing Segment by Application in 2021
Figure 3. Global Drug Repurposing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Drug Repurposing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Drug Repurposing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Drug Repurposing Revenue in 2021
Figure 8. By Type - Global Drug Repurposing Revenue Market Share, 2017-2028
Figure 9. By Application - Global Drug Repurposing Revenue Market Share, 2017-2028
Figure 10. By Region - Global Drug Repurposing Revenue Market Share, 2017-2028
Figure 11. By Country - North America Drug Repurposing Revenue Market Share, 2017-2028
Figure 12. US Drug Repurposing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Drug Repurposing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Drug Repurposing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Drug Repurposing Revenue Market Share, 2017-2028
Figure 16. Germany Drug Repurposing Revenue, (US$, Mn), 2017-2028
Figure 17. France Drug Repurposing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Drug Repurposing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Drug Repurposing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Drug Repurposing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Drug Repurposing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Drug Repurposing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Drug Repurposing Revenue Market Share, 2017-2028
Figure 24. China Drug Repurposing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Drug Repurposing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Drug Repurposing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Drug Repurposing Revenue, (US$, Mn), 2017-2028
Figure 28. India Drug Repurposing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Drug Repurposing Revenue Market Share, 2017-2028
Figure 30. Brazil Drug Repurposing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Drug Repurposing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Drug Repurposing Revenue Market Share, 2017-2028
Figure 33. Turkey Drug Repurposing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Drug Repurposing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Drug Repurposing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Drug Repurposing Revenue, (US$, Mn), 2017-2028
Figure 37. Astellas Pharma Drug Repurposing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Biovista Drug Repurposing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Drug Repurposing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. AbbVie Drug Repurposing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Drug Repurposing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Allergan Drug Repurposing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. NuMedii Drug Repurposing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)